Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milestone PharmaceuticalsMIST +3.42%22 Days Sales Outstanding is 353.00 as of Jun. 2026. GuruFocus rates MIST with a GF Score™ of 22/100. The stock has 5 warning signs investors should review. Among 841 Biotechnology companies, Milestone Pharmaceuticals ranks worse than 91.91% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Pharmaceuticals Days Sales Outstanding Chart
MIST vs UNCY, CNTB, EQ: Days Sales Outstanding Comparison
For the Biotechnology subindustry, Milestone Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Pharmaceuticals Days Sales Outstanding vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Milestone Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Milestone Pharmaceuticals's Days Sales Outstanding falls into.
Milestone Pharmaceuticals Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 353.00 mean?
Milestone Pharmaceuticals (MIST) has a Days Sales Outstanding of 353.00 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Milestone Pharmaceuticals and its competitors. According to the industry distribution chart, Milestone Pharmaceuticals ranks #773 out of 841 companies in the Biotechnology industry, placing it in the top 91.9%.
Is Milestone Pharmaceuticals' Days Sales Outstanding too high?
Milestone Pharmaceuticals' current Days Sales Outstanding is 353.00. The Biotechnology industry median Days Sales Outstanding is 68.98. Milestone Pharmaceuticals' value of 353.00 is 411.7% above this industry median. Based on the distribution chart, Milestone Pharmaceuticals ranks #773 out of 841 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Milestone Pharmaceuticals has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Milestone Pharmaceuticals' Days Sales Outstanding compare to UNCY and CNTB?
According to the Biotechnology industry distribution chart, Milestone Pharmaceuticals ranks #773 out of 841 companies for Days Sales Outstanding. This places Milestone Pharmaceuticals in the lower half of its industry. The industry median Days Sales Outstanding is 68.98. Milestone Pharmaceuticals' value of 353.00 is 411.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 68.98, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Pharmaceuticals's current Days Sales Outstanding of 353.00 is 411.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Milestone Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 68.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Pharmaceuticals's current Days Sales Outstanding is 353.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Pharmaceuticals stock overvalued right now?
Milestone Pharmaceuticals (MIST) has a current Days Sales Outstanding of 353.00. The current Days Sales Outstanding is 353.00 and 411.7% above the Biotechnology industry median of 68.98. Milestone Pharmaceuticals' overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current Days Sales Outstanding is 353.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
22GF Score
Get the complete analysis for MIST
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIST has been successfully added to your 
